Brexpiprazole: First global approval
The method of purification of the recombinant protein with a CBM3 tag was developed in both and yeast and has been proven successful in purifying several proteins [26, 27]
orally targeted delivery via functionalized nanoparticles
Food and Drug Administration (FDA), and are not intended to diagnose, treat, cure, or prevent any disease or medical condition
Furthermore, Toll-like receptor 4 (TLR4) is a crucial immune receptor that initiates the p38 MAPK pathway upon activation, which prompts the production of cytokines such as IL-1, IL-6 and IL-18
2012), where it was used as a control in our experiments